chr6-166307505-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_175922.4(PRR18):​c.638A>G​(p.Gln213Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000234 in 1,279,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 8.9e-7 ( 0 hom. )

Consequence

PRR18
NM_175922.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.44

Publications

0 publications found
Variant links:
Genes affected
PRR18 (HGNC:28574): (proline rich 18)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03570527).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRR18NM_175922.4 linkc.638A>G p.Gln213Arg missense_variant Exon 1 of 1 ENST00000322583.5 NP_787118.2 Q8N4B5
LOC107986669XR_001744464.2 linkn.-43T>C upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRR18ENST00000322583.5 linkc.638A>G p.Gln213Arg missense_variant Exon 1 of 1 6 NM_175922.4 ENSP00000319590.3 Q8N4B5

Frequencies

GnomAD3 genomes
AF:
0.0000133
AC:
2
AN:
150538
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000661
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
8.85e-7
AC:
1
AN:
1129320
Hom.:
0
Cov.:
60
AF XY:
0.00000184
AC XY:
1
AN XY:
542368
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23848
American (AMR)
AF:
0.00
AC:
0
AN:
9532
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14880
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27710
South Asian (SAS)
AF:
0.00
AC:
0
AN:
32302
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24234
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3392
European-Non Finnish (NFE)
AF:
0.00000105
AC:
1
AN:
948094
Other (OTH)
AF:
0.00
AC:
0
AN:
45328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000133
AC:
2
AN:
150646
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
73658
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41248
American (AMR)
AF:
0.0000660
AC:
1
AN:
15144
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5090
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67584
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 01, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.638A>G (p.Q213R) alteration is located in exon 1 (coding exon 1) of the PRR18 gene. This alteration results from a A to G substitution at nucleotide position 638, causing the glutamine (Q) at amino acid position 213 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.7
DANN
Benign
0.29
DEOGEN2
Benign
0.021
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.21
T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.036
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.90
L
PhyloP100
-2.4
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.86
N
REVEL
Benign
0.0090
Sift
Benign
0.65
T
Sift4G
Benign
0.51
T
Polyphen
0.0030
B
Vest4
0.019
MutPred
0.16
Gain of MoRF binding (P = 0.0141);
MVP
0.014
MPC
1.0
ClinPred
0.031
T
GERP RS
-4.1
Varity_R
0.051
gMVP
0.051
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769471812; hg19: chr6-166720993; API